Interaction of progestins with steroid receptors in human uterus

Lab / animal OA: closed
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-07-17 ⓘ

Norethindrone and norethindrone acetate competitively inhibited progesterone and estradiol binding to their respective receptors in the human uterus, with varying affinities.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

⚙ AI-generated deep summary by qwen3.7-flash, 2026-11-01 · read from full text ⓘ

This study investigated the competitive inhibition of progesterone and estradiol binding to their respective cytoplasmic receptors in human uterine tissue by various progestins, including norethindrone and its acetate ester. The researchers determined that while these compounds interfered with receptor binding, they possessed significantly lower affinity for the progestin receptor compared to native progesterone or other potent competitors like norgestrel. Additionally, the progestins demonstrated a minor inhibitory effect on estradiol binding to estrogen receptors, suggesting a complex interaction profile at the target site. Relevance to endometriosis: listed as one indication for GnRH antagonists, though the paper's main focus is uterine fibroids.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

Norethindrone (17beta-hydroxy-19-nor-17alpha-pregn-4-en-20-yn-3-one) and norethindrone acetate (17beta-acetoxy-19-nor-17alpha-pregn-4-en-20-yn-3-one) interfered to a varying degree, by competitive inhibition, with the binding of progesterone and oestradiol to respective cytoplasmic receptors in the human uterus. Progesterone binding to 4S macromolecule was saturable and co-specific for progestins. Competitors like norgestrel (17beta-hydroxy-18-methyl-19-nor-17alpha-pregn-4-en-20-yn-3-one), 19-norprogesterone, medroxyprogesterone acetate (17alpha-acetoxy-6alpha-methylpregn-4-ene-3,20-dione) and compound R(5020) (17,21-dimethyl-19-norpregna-4,9-diene-3,20-dione) possessed higher binding affinities for the progestin receptor. The dissociation constant (K(d)) for the progesterone-receptor interaction was 0.6-1.6nm and the receptor concentration ranged between 6600 and 8200 sites/cell. Norethindrone and norethindrone acetate competed for the progesterone receptor with inhibition constants (K(i)) of 6.8 and 72nm respectively. Gradient displacement and competitive-receptor assays indicated that norethindrone acetate-binding affinity for progestin receptor was approximately one-tenth that of norethindrone and progesterone. The progestins also inhibited oestradiol binding to 4.6S oestrogenic receptor by 8-12%, involving interaction at the oestradiol-binding site with a calculated K(i) value of 0.5-0.8mum. The competitive interaction of progestins with steroid receptors may be of putative importance in explaining the progestin action at the target site.
Full text 5,482 characters · extracted from oa-html · click to expand
Abstract Norethindrone (17β-hydroxy-19-nor-17α-pregn-4-en-20-yn-3-one) and norethindrone acetate (17β-acetoxy-19-nor-17α-pregn-4-en-20-yn-3-one) interfered to a varying degree, by competitive inhibition, with the binding of progesterone and oestradiol to respective cytoplasmic receptors in the human uterus. Progesterone binding to 4S macromolecule was saturable and co-specific for progestins. Competitors like norgestrel (17β-hydroxy-18-methyl-19-nor-17α-pregn-4-en-20-yn-3-one), 19-norprogesterone, medroxyprogesterone acetate (17α-acetoxy-6α-methylpregn-4-ene-3,20-dione) and compound R5020 (17,21-dimethyl-19-norpregna-4,9-diene-3,20-dione) possessed higher binding affinities for the progestin receptor. The dissociation constant (Kd) for the progesterone–receptor interaction was 0.6–1.6nm and the receptor concentration ranged between 6600 and 8200 sites/cell. Norethindrone and norethindrone acetate competed for the progesterone receptor with inhibition constants (Ki) of 6.8 and 72nm respectively. Gradient displacement and competitive-receptor assays indicated that norethindrone acetate-binding affinity for progestin receptor was approximately one-tenth that of norethindrone and progesterone. The progestins also inhibited oestradiol binding to 4.6S oestrogenic receptor by 8–12%, involving interaction at the oestradiol-binding site with a calculated Ki value of 0.5–0.8μm. The competitive interaction of progestins with steroid receptors may be of putative importance in explaining the progestin action at the target site. Full text PDFSelected References These references are in PubMed. This may not be the complete list of references from this article. - BURTON K. A study of the conditions and mechanism of the diphenylamine reaction for the colorimetric estimation of deoxyribonucleic acid. Biochem J. 1956 Feb;62(2):315–323. doi: 10.1042/bj0620315. [DOI] [PMC free article] [PubMed] [Google Scholar] - Baulieu E. E. Some aspects of the mechanism of action of steroid hormones. Mol Cell Biochem. 1975 Jun 30;7(3):157–174. doi: 10.1007/BF01731406. [DOI] [PubMed] [Google Scholar] - Bhatnagar S., Srivastava U. K., Takkar D., Chandra V. L., Hingorani V., Laumas K. R. Long-term contraception by steroid-releasing implants. II. A preliminary report on long-term contraception by a single silastic implant containing norethindrone acetate (ENTA) in women. Contraception. 1975 May;11(5):505–521. doi: 10.1016/0010-7824(75)90105-5. [DOI] [PubMed] [Google Scholar] - Chamness G. C., McGuire W. L. Scatchard plots: common errors in correction and interpretation. Steroids. 1975 Oct;26(4):538–542. doi: 10.1016/0039-128x(75)90073-2. [DOI] [PubMed] [Google Scholar] - Feil P. D., Miljković M., Bardin C. W. Medroxyprogesterone acetate: a steroid with potent progestational activity but low receptor affinity in the guinea pig uterus. Endocrinology. 1976 Jun;98(6):1508–1515. doi: 10.1210/endo-98-6-1508. [DOI] [PubMed] [Google Scholar] - Kontula K., Jänne O., Vihko R., de Jager E., de Visser J., Zeelen F. Progesterone-binding proteins: in vitro binding and biological activity of different steroidal ligands. Acta Endocrinol (Copenh) 1975 Mar;78(3):574–592. doi: 10.1530/acta.0.0780574. [DOI] [PubMed] [Google Scholar] - Korenman S. Use of receptor proteins for steroid-hormone assays. Methods Enzymol. 1975;36:49–52. doi: 10.1016/s0076-6879(75)36006-0. [DOI] [PubMed] [Google Scholar] - LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar] - Liao S., Liang T., Fang S., Castañeda E., Shao T. C. Steroid structure and androgenic activity. Specificities involved in the receptor binding and nuclear retention of various androgens. J Biol Chem. 1973 Sep 10;248(17):6154–6162. [PubMed] [Google Scholar] - MARTIN R. G., AMES B. N. A method for determining the sedimentation behavior of enzymes: application to protein mixtures. J Biol Chem. 1961 May;236:1372–1379. [PubMed] [Google Scholar] - McGuire J. L., DeDella C. In vitro evidence for a progestogen receptor in the rat and rabbit uterus. Endocrinology. 1971 Apr;88(4):1099–1103. doi: 10.1210/endo-88-4-1099. [DOI] [PubMed] [Google Scholar] - O'Malley B. W., Schrader W. T. The receptors of steroid hormones. Sci Am. 1976 Feb;234(2):32–43. doi: 10.1038/scientificamerican0276-32. [DOI] [PubMed] [Google Scholar] - Rosner J. M., Macome J. C., Denari J. H., De Carli D. N. Antioestrogenic action of chlormadinone acetate. Acta Endocrinol (Copenh) 1972 Feb;69(2):403–409. doi: 10.1530/acta.0.0690403. [DOI] [PubMed] [Google Scholar] - Smith H. E., Smith R. G., Toft D. O., Neergaard J. R., Burrows E. P., O'Malley B. W. Binding of steroids to progesterone receptor proteins in chick oviduct and human uterus. J Biol Chem. 1974 Sep 25;249(18):5924–5932. [PubMed] [Google Scholar] - Srivastava U. K., Laumas K. R. Long-term contraception by steroid-releasing implants. IV. Biological effectiveness of norethindrone acetate (ENTA) implants in rats and rabbits. Contraception. 1975 Nov;12(5):549–568. doi: 10.1016/0010-7824(75)90017-7. [DOI] [PubMed] [Google Scholar] - van Kordelaar J. B., Broekman M. M., van Rossum J. M. Interaction of contraceptive progestins and related compounds with the oestrogen receptor. Part I: Effect on (3H)oestradiol distribution pattern in the ovariectomized rat. Acta Endocrinol (Copenh) 1975 Jan;78(1):145–164. doi: 10.1530/acta.0.0780145. [DOI] [PubMed] [Google Scholar]

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

⚙ Ask this paper AI returns verbatim quotes from the full text · source: oa-html ⓘ

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

MeSH descriptors

Norethindrone Receptors, Estrogen Receptors, Progesterone Uterus Acetates Binding, Competitive Centrifugation, Density Gradient Cytosol Cytosol Estrogen Antagonists Estrogen Antagonists Female Humans In Vitro Techniques Kinetics Norethindrone Progesterone Progesterone Receptors, Estrogen Receptors, Progesterone

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

europepmc
last seen: 2026-11-01T09:25:17.647243+00:00
pubmed
last seen: 2026-10-08T21:58:49.153990+00:00
unpaywall
last seen: 2026-11-02T06:26:32.194460+00:00